Contact us
Menu
Contact us

Feldan News

on Dec 5,2018

Congratulations to Francois-Thomas Michaud for winning the “Visionary Entrepreneur of the Year” Award given by the CCIQ Chambre de commerce et d’industrie de Québec. Congratulations to Feldan Therapeutics’s team for its contribution to the success …

Read Story

on Nov 27,2018

Québec City, Canada, November 27, 2018 – Feldan Therapeutics (hereafter “Feldan”), a preclinical biotechnology company specialized in the intracellular delivery of therapeutic proteins and peptides, has announced an investment of …

Read Story

on Nov 14,2018

We are proud partner of the CRISPR congress 2019 to be held in Québec City, June 17-20, 2019. This annual event provides an international forum for scientists and organizations interested …

Read Story

on Oct 12,2018

Quebec City, Canada, October 12, 2018 – David Guay, Research Director of Feldan Therapeutics (hereafter “Feldan”) announced that his collaborator, Dr. Paul McCray from the University of Iowa Carver College …

Read Story

on Sep 18,2018

QUÉBEC CITY, Sept. 18, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan") has announced the closing of a $12.5 millions Series A financing round led by GC (parent company of GC Pharma), with the …

Read Story

on Jun 27,2018

Seoul (South Korea) & Québec City (Canada) June 27, 2018 – GC LabCell (hereafter “GCLC”) and Feldan Therapeutics (hereafter “Feldan”) announced an agreement today granting GCLC exclusive rights to use …

Read Story

on Jun 4,2018

Our CEO François-Thomas Michaud and Strategic development director Vincent Menard are pleased to be in Boston this week for the BIO convention. They are looking forward to meeting with international …

Read Story

on May 29,2018

QUEBEC CITY, May 29, 2018 - Feldan Therapeutics, Inc. announced today the issuance of a new patent related to the refinement of the Feldan Shuttle platform. This technology, a peptide-based delivery method …

Read Story

on May 1,2018

Feldan Therapeutics’ Research Director, Dr. David Guay, will be attending TIDES: Oligonucleotides and Peptide Therapeutics Conference next week, May 7-10th at Hynes Convention Center in Boston. Come to chat with …

Read Story

on Apr 9,2018

Our CEO Francois-Thomas Michaud and Strategic Alliance Director, Vincent Ménard, MBA Ph.D. will be attending RESI2018 conference in Toronto, April 10th. Come and meet with them to discuss how Feldan …

Read Story